Kanna Palaniappan, Ph.D., is a staff scientist at Freenome, where he leads a research program focused on identifying protein biomarkers for early cancer detection, and translating those markers into clinical products. Kanna obtained his Ph.D. from UC Berkeley, where he developed new tools for chemically-directly glycoproteomics and for MRI-based molecular imaging, in the laboratories of Professor’s Carolyn Bertozzi and Matthew Francis. Subsequently, he was an early member of the Google Life Sciences team and a founding member of Verily Life Sciences, where he worked on projects spanning nanotechnology to systems biology. Kanna joined Freenome in 2018 to build their protein research platform.